Navigation Links
Genetic variant mimics effect of heart failure medications
Date:4/20/2008

A genetic variation, found predominantly in African Americans, protects some people with heart failure, enabling them to live longer than expected. Thats the conclusion of a research team led by investigators at the University of Maryland School of Medicine in Baltimore and the Washington University School of Medicine in St. Louis. The researchers found that the genetic variation acts just like beta-blockers, a class of drugs used to treat chronic heart failure. Study results will be available in the online version of Nature Medicine (www.nature.com), on April 20, 2008.

In the study, the researchers found that African American heart failure patients with the genetic variation had a natural protection against death and the need for a heart transplant that is the same as the protection provided by beta-blocker therapy. Those patients who were given beta-blockers did not experience additional benefits from the medications because their own genetic beta blockade was already protecting them.

The researchers say their discovery adds to the accumulating evidence that genetic differences contribute to the way people respond to medications, and should encourage the use of genetic testing in clinical trials to identify people who can benefit from therapy tailored to their personal genetic makeup. This is a significant development in our understanding of why some African American patients appear to not respond to beta-blockers in the same way as Caucasian patients, says one of the studys co-authors, Stephen B. Liggett, M.D., professor of medicine and physiology at the University of Maryland School of Medicine and director of its cardiopulmonary genomics program. In this case, it seems that this genetic variation is a good thing, mimicking drugs that are frequently use
'/>"/>

Contact: Bill Seiler
bseiler@umm.edu
410-484-7317
University of Maryland Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Does the desire to consume alcohol and tobacco come from our genetic makeup?
2. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
3. Many parents at-risk for cancer disclose genetic test results to children
4. Genetics determine optimal drug dose of common anticoagulant
5. Claims of sex-related differences in genetic association studies often not properly validated
6. American College of Medical Genetics responds to new FDA labeling decision for warfarin
7. UNC study questions FDA genetic-screening guidelines for cancer drug
8. Genome study shines light on genetic link to height
9. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
10. Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring
11. Rutgers Genetics receives $7.8 million for autism research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2014)... constantly wages war on the human body. Battles ... stalemate. In pancreatic cancer, this stalemate—known as tumor ... aggressively malignant, a phenomena that is poorly understood. ... the laboratory of Salvatore Torquato, a Professor of ... conditions surrounding tumor dormancy and the switch to ...
(Date:10/16/2014)... tract infections and worldwide claims the lives of ... Ghent University have succeeded in developing a promising ... , Xavier Saelens (VIB/UGent): "We discovered a ... the development of a novel approach to vaccination ... numerous small children and elderly people." , ...
(Date:10/15/2014)... is a non-traditional biophysics textbook and it describes how ... journey of discovery into biological systems and provides an ... It is about how our genes make proteins that ... of cells in an organism. It quantifies the principles ... can be found on both large and small scales. ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2New perspectives for development of an RSV vaccine 2New book about life as seen from physics 2
... help scientists "build" new biological systems, Princeton University scientists ... enable the growth of living cells. The team ... nature, and the scientists showed that they can produce ... as proteins produced by nature,s own toolkit. ...
... ATHENS, Ohio (Jan. 6, 2011) Ohio University ... the bioengineering profession,s highest honor, the Fritz J. and ... Hood of Seattle, Washington, for his discoveries related to ... president and co-founder of the Institute for Systems Biology, ...
... at the University of Connecticut Health Center have identified a ... a predictor of heart attack. Their research, led by ... Cardiology Center, is published in the Jan. 11 issue of ... It found heart attack patients had elevated levels of the ...
Cached Biology News:Princeton scientists construct synthetic proteins that sustain life 2Princeton scientists construct synthetic proteins that sustain life 3DNA sequencing pioneer receives 2011 Russ Prize 2DNA sequencing pioneer receives 2011 Russ Prize 3
(Date:10/22/2014)... (PRWEB) October 22, 2014 According ... Market by Service Type (Consulting, Integration, Deployment & ... by Deployment Model (Public, Private, Others (Hybrid & ... MarketsandMarkets, defines and segments the Cloud Professional Services ... and forecasting of revenues. It also identifies the ...
(Date:10/22/2014)... and HONG KONG , Oct. 22, ... therapeutics enterprise, announced today that rare disease expert ... vice president, research. Dr. McKew brings more than two ... positions at the National Institutes of Health, Wyeth Research ... Wyeth). Dr. McKew will lead aTyr,s efforts to expand and ...
(Date:10/20/2014)... , Oct. 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ... million which brings Q3 orders to $5.8 million and provides a ... projects in North America and one in ... to bid new projects at record levels," said Peter Bruijns ... higher at the end of Q3 than they have been for ...
(Date:10/20/2014)... Earle Martin , Chief Executive ... Ellen Teplitzky, an experienced attorney specializing in business ... has joined the firm as Director of Legal ... NDA Partners provides legal services, including research, ... top law firms and their clients in cases ...
Breaking Biology Technology:Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 3Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 4Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 5aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2
... (NYSE: DGX ), the world,s leading provider ... for the fourth quarter ended December 31, 2011, adjusted ... per diluted share, compared to $179 million, or $1.03 ... of 2011, reported income from continuing operations was $190 ...
... Lieber, the Mark Hyman Jr. Professor of Chemistry, ... A pioneer in the synthesis of a wide ... unique physical properties of those materials, and the ... Lieber has demonstrated the use of nanoscale materials ...
...  A recent Van Andel Research Institute (VARI) study published in ... function of an essential plant hormone could profoundly change our ... to the development of new drugs for a variety of ... by the same team of investigators at VARI that was ...
Cached Biology Technology:Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 2Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 3Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 4Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 5Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 6Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 7Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 8Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 9Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 10Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 11Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 12Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 13Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 14Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 15Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 16Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 17Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 18Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 19Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 20Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 21Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 22Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 23Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 24Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 25Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 26Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 27Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 28Van Andel Research Institute Study Provides New Details of Fundamental Cellular Process 2
Biotin d anti-mouse Tim-1...
Mouse monoclonal [1-N-14] to Adenovirus Type 7 hexon C11 Immunogen: Purified Adenovirus type 7 Specificity: This antibody is specific for Adenovirus type 7 hexon C11....
Request Info...
... is the main excitatory neurotransmitter in the ... considered to act only on the ligand-gated ... that are involved in the fast excitatory ... to regulate enzymes producing second messengers via ...
Biology Products: